Basics |
Enliven Therapeutics, Inc.
|
IPO Date: |
February 24, 2023 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$1.28B |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.61 | 3.21%
|
Avg Daily Range (30 D): |
$0.83 | 3.90%
|
Avg Daily Range (90 D): |
$0.73 | 3.73%
|
Institutional Daily Volume |
Avg Daily Volume: |
.19M |
Avg Daily Volume (30 D): |
.51M |
Avg Daily Volume (90 D): |
.36M |
Trade Size |
Avg Trade Size (Sh.): |
66 |
Avg Trade Size (Sh.) (30 D): |
75 |
Avg Trade Size (Sh.) (90 D): |
66 |
Institutional Trades |
Total Inst.Trades: |
535 |
Avg Inst. Trade: |
$1.52M |
Avg Inst. Trade (30 D): |
$1.44M |
Avg Inst. Trade (90 D): |
$1.14M |
Avg Inst. Trade Volume: |
.07M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$1.5M |
Avg Closing Trade (30 D): |
$1.68M |
Avg Closing Trade (90 D): |
$1.16M |
Avg Closing Volume: |
70.32K |
|
|
Financials |
|
TTM |
Q4 2024 |
FY 2024 |
Basic EPS
|
$-.57
|
$-.46
|
$-1.89
|
Diluted EPS
|
$-.57
|
$-.46
|
$-1.89
|
Revenue
|
$ M
|
$ M
|
$ M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -28.54M
|
$ -23.18M
|
$ -89.02M
|
Operating Income / Loss
|
$ -31.69M
|
$ -26.9M
|
$ -104.55M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ -22.47M
|
$ 23.5M
|
$ 23.98M
|
PE Ratio
|
|
|
|
|
|
|